Matthews, David R.
Li, Qiang
Perkovic, Vlado
Mahaffey, Kenneth W.
de Zeeuw, Dick
Fulcher, Greg
Desai, Mehul
Hiatt, William R.
Nehler, Mark
Fabbrini, Elisa
Kavalam, Mary
Lee, Mary
Neal, Bruce
Funding for this research was provided by:
Janssen Research & Development, LLC
Article History
Received: 15 October 2018
Accepted: 28 January 2019
First Online: 12 March 2019
Duality of interest
: DRM reports receiving support from Janssen for his role as co-chair of the CANVAS Program steering committee. QL reports being a full-time employee of the George Institute for Global Health. VP reports receiving personal fees for advisory boards or scientific presentations from Retrophin, Janssen, Merck and Servier, serving on steering committees for trials funded by AbbVie, Boehringer Ingelheim, GlaxoSmithKline, Janssen and Pfizer and participating in scientific presentations/advisory boards with AbbVie, Astellas, Astra Zeneca, Bayer, Baxter, Bristol-Myers Squibb, Boehringer Ingelheim, Durect, Eli Lilly, Gilead, GlaxoSmithKline, Novartis, Novo Nordisk, Pharmalink, Relypsa, Sanofi and Vitae, with all fees paid to his employer. KWM reports receiving grants from Afferent, Amgen, Apple Inc., AstraZeneca, Cardiva Medical, Daiichi, Ferring, Google (Verily), Johnson & Johnson, Luitpold, Medtronic, Merck, Novartis, Sanofi, St Jude and Tenax, receiving personal fees from Ablynx, AstraZeneca, Baim Institute, Boehringer Ingelheim, Bristol-Myers Squibb, Cardiometabolic Health Congress, Elsevier, GlaxoSmithKline, Johnson & Johnson, Medscape, Merck, Mitsubishi, Myokardia, Novartis, Oculeve, Portola, Radiometer, Springer Publishing, Theravance, University of California San Francisco and WebMD and having equity in BioPrint Fitness. DdZ reports serving on advisory boards and/or as a speaker for Bayer, Boehringer Ingelheim, Fresenius, Mundipharma and Mitsubishi-Tanabe, being a steering committee member and/or speaker for AbbVie and Janssen and serving on Data Safety and Monitoring Committees for Bayer. GF reports receiving grants from Novo Nordisk and personal fees from Janssen, Novo Nordisk, Boehringer Ingelheim and Merck Sharp & Dohme. MD, EF, MK and ML report being full-time employees of Janssen Research & Development, LLC. MK reports holding stock in Johnson & Johnson. WRH reports receiving grants from Janssen and Bayer. MN reports receiving salary support from CPC Research. BN reports receiving grants and travel costs related to presentation of data from Janssen and serving on advisory boards for Janssen, with any consultancy, honoraria or travel support paid to his institution. No other potential conflicts of interest relevant to this article are reported.